Monday, February 13, 2012

All SharePosts Relating To "telcagepant"

Expert_badge Teri Robert

Teri Robert

(Profile)
Author of "Living Well with Migraine Disease and Headaches"

New Migraine and Headache Info on MMC, 4/28/10

Hello, everyone! For those of you who are super busy or don't feel well enough to look around for what's new, each week, I'll be posting links for you here. Links to the newest Migraine and headache information we've made available here on MyMigraineConnection. Without further ado, here's some of the newest information we've published ... Read moreChevron
posted 04/28/2010, comments (0)|
Expert_badge Teri Robert

Teri Robert

(Profile)
Author of "Living Well with Migraine Disease and Headaches"

Telcagepant for Migraine - 4/10 Update

Finding an effective Migraine abortive treatment can be challenging, especially for Migraineurs who have any history of or risk factors for stroke and other cardiovascular disease and events. The triptans -- Imitrex, Maxalt, Zomig, Amerge, Relpax, Axert, and Frova -- and the ergotamines -- DHE and Migranal -- all present potential ... Read moreChevron
Expert_badge Nancy Harris Bonk

Nancy Harris Bonk

(Profile)
Community Manager

New Migraine Drug Telcagepant Delayed

Merck & Company's new Migraine drug Telcagepant which was recently hoping to win FDA approval, has been delayed. The small phase IIa clinical study was stopped after participants' liver enzymes were high while taking the medication on a daily basis.    Telcagepant is an antagonist of the receptor for... Read moreChevron
posted 04/23/2009, comments (0)|
Expert_badge Teri Robert

Teri Robert

(Profile)
Author of "Living Well with Migraine Disease and Headaches"

New Migraine Abortive Telcagepant Performs Well In Trials

Last year, we looked at Phase II clinical trials of MK-0974, an investigational oral calcitonin gene-related pepitide (CGRP) receptor antagonist, a new type of Migraine abortive. That medication has now been named telcagepant, and is showing great promise as a new Migraine abortive. When I spoke with lead researcher, Dr. Tony Ho, last year, he... Read moreChevron